kresmion.
Pull a receipt
PREVIEW · SAMPLE DATA
This is the NVS dossier with made-up numbers. Sign up free to see live prices, insider trades, 13F flows and fundamentals for NVS.

NVS

NOVARTIS AG
Pharmaceuticals · Pharmaceuticals
$152.09 sample
-2.37 (-1.53%) 1D
☆ Watch
Market cap
$954.4B
Price as of
2026-10-29
Latest filing
8-K · 2026-10-21
Alerts
8
Price$152.09 +6.04% 3M daily closessample
158.67139.23
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first
  • Oct 21SECForm 144 filed
  • Oct 12INSInsider sell: EVP, Operations
  • Oct 07INSInsider buy: Director
  • Sep 29SECForm 144 filed
  • Sep 24INSInsider buy: Chief Financial Officer
  • Sep 21SEC10-Q filed
  • Sep 16INSInsider buy: EVP, Operations
  • Sep 11INSInsider buy: General Counsel
Sign up to see the real NVS record →

Company facts

SEC EDGAR registration
Name
NOVARTIS AG
Sector
Pharmaceuticals
Industry
Pharmaceuticals
Smart-money score
-14sample, -100 to +100
Reporting currency
USD

Who is positioning in NVS

sample
Insiders
14 insider transactions over 90 days, net selling, $741.1M
Congress
3 members traded over 90 days
Institutions · 13F
7 funds hold $19.4B
Activists · 13D/G
No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end
Revenue$41.9B +15.9% y/y
Q4 2024Q3 2026
Inventory$23.4B +12.0% y/y
Q4 2024Q3 2026
Accounts receivable$18.3B +16.7% y/y
Q4 2024Q3 2026
Total debt$50.6B +12.6% y/y
Q4 2024Q3 2026

Peers

sample
Sample peer A
$866.2B +1.1% 3M
Sample peer B
$766.5B +1.3% 3M
Sample peer C
$528.9B -5.2% 3M
Sample peer D
$279.7B -3.5% 3M
Sample peer E
$102.1B -5.0% 3M
Preview. Company name, sector and industry are from SEC EDGAR; every price, flow, filing count and fundamental on this page is sample data generated for the preview and is not NVS's real figure. Nothing here is investment advice.